Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CACI International Inc (NYSE: CACI) SEC filings page brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering investors a structured view of how this national security-focused information solutions and services provider reports material events, financing arrangements, governance actions, and strategic transactions. CACI’s filings appear under its registrant name and document its activities as a public company serving primarily U.S. government agencies and departments.
Through this page, readers can access current and historical Forms 8-K in which CACI reports items such as quarterly and annual financial results, amendments to credit agreements, accounts receivable purchase arrangements, incentive compensation plans, and board and committee matters. Recent 8-K filings, for example, describe a Second Amended and Restated Credit Agreement with specified term loan and revolving credit facilities, amendments to a Master Accounts Receivable Purchase Agreement, and shareholder approval of the CACI International Inc 2025 Incentive Compensation Plan.
Filings also capture strategic transactions and acquisition agreements. An 8-K dated December 22, 2025 outlines a Purchase Agreement and Plan of Merger under which a CACI subsidiary agreed to acquire ARKA Group L.P. for an aggregate cash purchase price, subject to customary conditions and regulatory approvals. Related disclosures include information on planned debt financing commitments and bridge loan facilities associated with that transaction.
Investors can use this page to locate quarterly and annual reports (Forms 10-Q and 10-K when available), which provide more detailed discussions of segment operations, risk factors, and financial statements, as well as proxy materials such as the DEF 14A that describe director elections, advisory votes on executive compensation, and auditor ratification. Stock Titan’s platform adds AI-powered summaries to help explain the key points in lengthy filings, highlight important sections, and make it easier to interpret complex topics like leverage covenants, incentive plans, and acquisition structures.
For users analyzing CACI stock, this SEC filings page serves as a centralized resource for understanding how the company documents its national security-oriented business, capital structure, governance, and material events in its official regulatory reports.
CACI International Inc reported higher results for the quarter ended December 31, 2025. Revenue rose to
For the first six months of the fiscal year, revenue reached
CACI International Inc reported that it has released its financial results for the second quarter of its fiscal year 2026. The company furnished a press release with these results as Exhibit 99.1, which also includes details about a conference call and webcast. The call and webcast are scheduled for January 22, 2026, giving investors and analysts an opportunity to hear management discuss the quarter’s performance.
BlackRock, Inc. has filed an amended Schedule 13G/A reporting its beneficial ownership of 1,967,663 shares of CACI INTERNATIONAL INC Class A Stock as of the event date 12/31/2025. This holding represents 8.9% of the outstanding class, making BlackRock a significant institutional shareholder.
BlackRock reports sole voting power over 1,891,158 shares and sole dispositive power over all 1,967,663 shares, with no shared voting or dispositive power. The filing explains that the position is held by certain BlackRock business units in the ordinary course of business and states that the securities were not acquired and are not held for the purpose of changing or influencing control of CACI INTERNATIONAL INC.
CACI International director Philip O. Nolan reported the vesting and conversion of 84 Restricted Stock Units into 84 shares of CACI common stock on January 14, 2026. The Form 4 shows this as a transaction with no exercise price. These RSUs are part of a 338-unit grant awarded on October 17, 2025, which is scheduled to vest in four installments through October 11, 2026. After this vesting event, Nolan directly holds 2,153 shares of CACI common stock and 254 RSUs, reflecting his ongoing equity-based compensation as a director.
CACI International director Charles L. Szews reported the vesting of previously granted equity awards. On January 14, 2026, 84 Restricted Stock Units (RSUs) that were granted on October 17, 2025 vested and were converted into 84 shares of CACI common stock at an exercise price of $0.00 per share.
After this transaction, Szews directly owns 415 shares of CACI common stock and 254 RSUs, which are scheduled to vest later under the original grant of 338 RSUs. The remaining RSUs are expected to vest in three additional installments on April 14, 2026, July 13, 2026, and October 11, 2026.
CACI International director Scott C. Morrison reported the vesting and conversion of restricted stock units into common shares. On January 14, 2026, 84 Restricted Stock Units vested and were converted into 84 shares of CACI common stock at a price of $0.00 per share, reported with transaction code "M". After this transaction, Morrison directly owned 415 shares of CACI common stock and 254 Restricted Stock Units. These RSUs are part of a 338-unit grant made on October 17, 2025 that vests in four installments through October 11, 2026.
CACI International director Susan M. Gordon reported a routine equity compensation vesting. On January 14, 2026, 84 Restricted Stock Units (RSUs) previously granted to her converted into CACI common stock at an exercise price of $0 per share. These RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026.
Following this transaction, Gordon directly beneficially owned 2,821 shares of CACI common stock and 254 RSUs, reflecting ongoing board compensation rather than an open-market purchase or sale.
CACI International director Stanton D. Sloane reported the vesting of 84 Restricted Stock Units (RSUs) into 84 shares of CACI common stock on January 14, 2026, at an exercise price of $0 per share. After this transaction, he beneficially owned 943 shares of CACI common stock and 254 RSUs directly.
These RSUs are part of a 338-unit grant awarded on October 17, 2025, with a scheduled vesting of 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa Disbrow reported equity awards tied to her board service. On January 14, 2026, 123 Restricted Stock Units (RSUs) vested and were settled into 123 shares of CACI common stock, leaving her with 2,110 directly held shares and 369 RSUs still outstanding from a 492-unit grant made on October 16, 2025. On January 15, 2026, she received an additional 44 shares of common stock in connection with her annual retainer as Chair of the Board, bringing her direct holdings to 2,154 shares.
CACI International Inc. director Debora A. Plunkett reported the vesting of restricted stock units and corresponding issuance of common shares. On January 14, 2026, 84 Restricted Stock Units converted at an exercise price of $0.0000 per unit into 84 shares of CACI common stock, reported as a transaction with code "M." Following this transaction, she directly held 2,648 shares of CACI common stock and 254 Restricted Stock Units.
The footnote explains that on October 17, 2025, she was granted 338 Restricted Stock Units, scheduled to vest in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
FAQ
What is the current stock price of Caci Intl (CACI)?
What is the market cap of Caci Intl (CACI)?
